Abstract. evidence suggests that the volume of the amygdala is significantly reduced in patients with post-traumatic stress disorder (PTSD), and that this may be related to neuronal apoptosis. However, the precise molecular mechanism of this decrease in amygdala volume during PTSD remains unclear. In this study, we investigated the relationship between the activity of the 5-HT1A receptor and amygdala neuronal apoptosis. Rats were exposed to a single-prolonged stress (SPS) procedure to create a PTSD rat model, with or without prior treatment with WAY100635, a 5-HT1A receptor antagonist. The expression of Bax, a pro-apoptotic protein, and Bcl-2, an anti-apoptotic protein, was examined by Western Blotting. TUNEL staining and flow cytometry (FCM) were employed for the detection of apoptotic cells in the amygdala. Our results indicate that SPS induces amygdala neuronal apoptosis, which was partially inhibited by WAY100635, and suggest that this apoptosis may be related to the activity of the 5-HT1A receptor.
Introduction
Post-traumatic stress disorder (PTSD) is an anxiety disorder that develops after endurance of a life-threatening traumatic experience and consists of re-experiencing trauma with distressing recollections, dreams, flashbacks, psychological/ physical distress, persistent avoidance of stimuli that might invite traumatic memories or expericences, and increased emotional arousal (1) . The exact mechanism of PTSD remain elusive. Single-prolonged stress (SPS) appears to induce enhanced inhibition of the hypothalamic-pituitary-adrenal (HPA) axis, which is a putative neuroendocrinological hallmark of PTSD. SPS paradigms have been extensively applied in the investigation of PTSD.
PTSD is thought to involve the dysregulation of amygdala activity in response to fear. Certain regions of the brain, in particular the amygdala and hippocampus, are involved in the pathophysiology of PTSD. The amygdala is the main output center of response to fearful stimuli (2) , and has been documented to be responsible for the enhancement of explicit memories associated with emotional arousal (3, 4) . The amygdala is closely related to the hippocampus, and the clinical course of PTSD is driven by pathophysiological changes in these brain regions. Abundant evidence suggest that the volume of the amygdala in patients suffering from PTSD is significantly reduced (5,6). Ding et al detected the expression of apoptosis-related genes and observed morphological changes in the amygdala neurons of PTSD rats (7) . Apoptosis is regulated by various classes of proteins, including the proapoptotic protein Bax and the anti-apoptotic protein Bcl-2. The Bax/Bcl-2 ratio appears to be a critical threshold parameter for apoptosis (8, 9) . Serotonin (5-hydroxytryptamine, 5-HT), a type of neurotransmitter, plays an important role in controlling complex neuronal communication, such as the negative feedback of the HPA axis via the serotonergic receptor (10, 11) . It has been proposed that the serotonergic type 1A (5-HT1A) receptor plays a crucial role in mood and anxiety modulation (12, 13) . However, the role of the serotonin receptor in PTSD appears contradictory (14, 15) . One of our previous studies revealed that the 5-HT1A receptor is involved in the alteration of glucocorticoid receptor in the hippocampus and corticotropin releasing factor in the hypothalamus in SPS rats (16) . Whether the 5-HT1A receptor is activated during SPS in the amygdala and whether its role in apoptosis is induced by SPS remains to be determined. In the present study, rats were exposed to SPS with or without prior treatment with the 5-HT1A receptor antagonist WAY100635, and the expression of Bax/Bcl-2 and apoptotis in the amygdala of the SPS rats was examined in order to elucidate the role of the 5-HT1A receptor in apoptotis.
Materials and methods
Animals. Healthy male Wistar rats (n=45) weighing 180-220g were obtained from the Experimental Animal Center of China Medical University. Prior to the experiment, they were reared Activity of 5-HT1A receptor is involved in neuronal apoptosis of the amygdala in a rat model of post-traumatic stress disorder in the experimental animal facility for a week to acclimate them to the new environment: temperature 18-20˚C, humidity 50-60%, and lights on from 07:00 to 19:00. Standard food pellets and tap water were available ad libitum. All procedures followed national guidelines for animal care.
Animal PTSD model and experimental groups. The rats were randomly divived into three groups: the control group, the model group and the blockade group. The model and blockade groups were injected with either solvent or WAY100635 30 min prior to undegoing the SPS procedure. The control rats were administred an equal volume of solvent. The PTSD model was created as previously described (17) . Briefly, rats were restrained for 2 h and then immediately forced to swim for 20 min in water at 24˚C. After a 15-min rest, they were anaesthetized by ether and then placed in their home cages without disturbance.
Drug infusion procedure. WAY100635 (Sigma, USA) was dissolved in DMSO (50 mg/ml) and stored at -20˚C. The solution was diluted in physiological normal saline before use to a final concentration of 0.5 mg/ml. A dose of 3.0 mg/kg WAY100635 was administered by subcutaneous infusion (18) .
Western blotting for Bax and Bcl-2.
Seven days after exposure to SPS, five rats in each group were decapitated and Western blotting was used to determine the levels of Bax/Bcl-2 in the amydala. The brains were removed and the basolateral amygdala was dissected according to the atlas of Paxinos and Watson (19) . Tissue samples were homogenized in ice-cold lysis buffer containing 50 mM Tris-HCl (pH 7.4), 1% NP-40, 0.25% nadeoxycholate, 150 mM NaCl, 1 mM PMSF, 1 mM EDTA, 1 mg/ml pepstatin, 1 mM Na 3 VO 4 and 1 mM NaF. Crude homogenates were incubated on ice for 30 min and centrifuged at 15,000 g for 30 min at 4˚C. The supernatant was collected for protein assay and stored at -70˚C. Samples (30 µg protein per lane) were separated in 10% SDS-PAgE and transferred onto PVDF membranes. The membranes were blocked in blocking solution (5% skim milk, 10 mM Tris-HCl, 100 mM NaCl, 0.01% Tween-20) for 2 h at room temperature, immersed in mouse monoclonal anti-Bax or antiBcl-2 antibodies (1:1000; Cell Signaling, Beverly, MA, USA) and maintained overnight at 4˚C. Membranes were washed three times for 10 min each in TBST (10 mM Tris-HCl, 100 mM NaCl, 0.01% Tween-20) and incubated for 2 h with horseradish peroxidase-conjugated secondary antibody and goat polyclonal anti-mouse Igg (1:2500; Boster Biological Technology Ltd., Wuhan, China). After the membranes were washed, the specific bands were detected by an ECL system. β-actin was used for the controls. The bands were analyzed by the gel Image Analysis System (Tanon 2500R, Shanghai, China). Each Bax or Bcl-2 band was normalized to β-actin values and expressed as the intensity ratio.
Double-labeled flow cytometry for cell apoptosis rate. Seven days after exposure to SPS, five rats from each group were decapitated and double-labeled flow cytometry (FCM) was used to determine the rate of cell apoptosis. The basolateral amygdala was dissected as above and placed into cold PBS to form a single-cell suspension. The final concentration was adjusted to 1x10 4 cells/ml. Then, 1 ml of the suspension was centrifuged at 1000 g for 10 minutes at 4˚C to isolate the supernatant. Finally, 1 ml of cold PBS was added and the supernatant was gently agitated. Centrifugation was repeated three times to obtain the cell pellets. The cell pellets were resuspended in 200 µl binding buffer and then incubated with 10 µl Annexin V-FITC and 5 µl propidium iodide for 15 min at room temperature. After the addition of 300 µl binding buffer, the solution was analyzed by flow cytometry (Becton Dickinson, USA) within one hour.
Brain tissue preparation and TUNEL staining analysis for cell apoptosis. Seven days after exposure to SPS, five rats from each group were transcardially infused with 200-300 ml of pre-cold saline through the ascending aorta, followed by 300 ml of 0.01 M PBS (pH 7.4) containing 4% pre-cold paraformaldehyde. TUNEL staining was performed as follows: the whole brains were rapidly removed after perfusion fixation with 4% paraformaldehyde in 0.01 M PBS, dehydrated in alcohol and embedded in paraffin. Next, 5-µm-thick slices were cut from the paraffin-embedded tissues, washed three times in 0.01 M PBS, then permeabilized in proteinase K for 10 min. Endogenous peroxidase was deactivated by 0.3% hydrogen peroxide. After another three washes, the sections were incubated in TdT buffer at 37˚C for 1 h and then with antibody at 37˚C for 1 h. The sections were stained by DAB with hematoxylin counterstaining and mounted on a light microscope. Five random slides were selected from each group, and from each slide five randomly selected visual fields in the amydala were observed at a magnification of x40. The number of TUNEL-positive cells was counted, and the TUNEL-positive cell rate was defined as the (number of TUNEL-positive cells/total number of cells) x 100%.
Statistical analysis.
Values are presented as the means ± standard error of the mean (SEM) and were analyzed using SPSS 13.0. Statistical significance was determined by one-way analysis of variance (ANOVA), followed by the Tukey's test when appropriate. A P-value <0.05 was considered to indicate a statistically significant difference.
Results
Bax/Bcl-2 ratio. As seen in Fig. 1 , a significant difference in the Bax/Bcl-2 ratio was observed between the SPS model rats and the control rats (midbrain raphe, 1.39±0.07 vs. 0.46±0.04, P<0.01). The same result was observed between the model group and the blockade group: the ratio of Bax/Bcl-2 was significantly increased in the SPS rats (midbrain raphe, 1.39±0.07 vs. 0.79±0.06, P<0.01). In the rats infused with WAY100635 prior to SPS treatment, the SPS-induced increase in the ratio of Bax/Bcl-2 in the amygdala was significantly abolished (P<0.01).
Apoptosis rate. Αpoptotic cells were detected by Annexin V/ PI staining in the experimental groups. As shown in Fig. 2 , the amygdala cells from the SPS model group underwent considerable apoptosis. ANOVA revealed significant differences among three groups (F 2,12 =64.640, P<0.01). As shown in Fig. 3 , a significant difference in the apoptotic rate was observed between the SPS model rats and the control rats (midbrain raphe, 16.33±1.62 vs. 3.01±0.61, P<0.01), and between the model group and the blockade group (midbrain raphe, 16.33±1.62 vs. 7.77±1.04, P<0.01). These data indicate that SPS made the amygdala cells prone to apoptosis. In rats infused with WAY100635, the SPS-induced increased in the rate of apoptosis in the amygdala was significantly abolished.
Number and rate of TUNEL-positive cells. The number of TUNEL-positive cells in the control, model and blockade groups was 12.33±1.25, 62.49±7.86 and 38.83±5.08, respectively. ANOVA revealed significant differences among the three groups (F 2,12 =227.567, P<0.01). As shown in Fig. 4 , the number of TUNEL-positive cells in the model group was significantly increased compared to the control group (P<0.01), while the number of TUNEL-positive cells in the blockade group was significantly decreased compared to the model group (P<0.01). . Analysis of the apoptosis rate by flow cytometry in the amygdala of the various groups (n=5 for each group). Statistical analysis was carried out by one-way ANOVA (F 2,12 =64.640, P<0.01) followed by Tukey's test. ** P<0.01 compared to the control group, ## P<0.01 compared to the model group. Figure. 4 . Analysis of the TUNEL-positive cell rate (n=5 per group). Statistical analysis was carried out by one-way ANOVA (F 2,12 =227.576, P<0.01) followed by Tukey's test. ** P<0.01 compared to the control group, # P<0.05 compared to the model group.
A B C Discussion
PTSD is a stress-related mental disorder caused by a traumatic experience, and is believed to involve the dysregulation of the medial prefrontal cortex and amygdala activity in response to fear. This complex syndrome includes re-experiencing memories (nightmares and flashbacks), symptoms of hyperarousal (e.g., insomnia), numbing symptoms (blunted affect and anhedonia), avoidance symptoms (avoiding trauma-related stimuli), poor concentration and difficulty explicitly recalling aspects of the traumatic event. Since the incidence of wars, violence, natural disasters and major traffic accidents has increased, the incidence of PTSD is on the rise. Therefore, the pathogenesis of PTSD must be precisely elucidated. SPS induces enhanced inhibition of the HPA axis, a putative neuroendocrinological hallmark of PTSD, presents behavioral alterations resembling those of PTSD and has the most consistent neuroendocrinologic characteristics in PTSD patients (17, (20) (21) (22) (23) . Previous studies have revealed that SPS rats exhibit an exaggerated acoustic startle response (24) and enhanced contextual freezing (21, 25) . These findings suggest that SPS causes an enhanced sensitivity to stimuli, which resembles trauma-related and -unrelated psychophysiological responses in patients with PTSD. SPS is therefore a good animal model of PTSD based on the time-dependent dysregulation of the HPA axis. In the present study, rats were exposed to SPS to elucidate the pathogenesis of PTSD.
PTSD exhibits four major types of characteristic symptoms: re-experiencing, avoidance, numbing and hyperarousal, suggesting a heightened fear response. Previous studies have demonstrated that the left amygdala volume in PTSD patients is significantly reduced (5, 6, 26, 27) . The amygdala is the main output center of response to fearful stimuli (2), and has been documented to be responsible for the enhancement of explicit memories associated with emotional arousal (3, 4) . PTSD is believed to involve the dysregulation of amygdala activity in response to fear. It has been suggested that the volume of the amygdala in patients with PTSD is significantly reduced (5, 6) . The basolateral nucleus is the largest subgroup of the amygdala (28, 29) , and is the key region of fear initiation. Our previous study detected the expression of apoptosis-related genes and observed morphological changes in the asolateral amygdala neurons of PTSD rats (7) .
In this study, we investigated the relationship between the SPS-induced activity of the 5-HT1A receptor and apoptosis in the basolateral amygdala. Our results revealed that the Bax/ Bcl-2 ratio, the apoptotic cell rate and the number of TUNELpositive cells in the amygdala increased after the rats were exposed to SPS, suggesting that neuronal apoptosis of the amygdala is induced by SPS. Therefore, apoptosis may play an important role in the decrease in amygdala volume observed in PTSD. Moreover, the results of this study revealed that the apoptosis increase induced by SPS was significantly abolished by WAY100635, an antagonist of the 5-HT1A receptor. Thus, the 5-HT1A recepor may be one of the factors that induces neruon apoptosis in the amygdala.
In conclusion, we demonstrated that apoptosis in the amygdala is associated with the activity of the 5-HT1A receptor. The results suggest that the 5-HT system and apoptosis may play crucial roles in PTSD. The detailed mechanisms of 5-HT and the receptor system in the pathophysiology of stress-related disorders warrants further investigation.
